Robert Quaife

Robert Quaife

Auto-generated profile, based on publicly available information

Robert Quaife

Division of Cardiology, Department of Medicine (N.L.A., R.A.Q., E.A.G., M.R.B.), University of Colorado School of Medicine, Anschutz Medical Campus, Aurora

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2023 in Circulation Research
Verified
Journal Article
Closed access
NANatasha L. Altman
Natasha L. Altman
ABAmber A. Berning
Amber A. Berning
SMSarah C. Mann
Sarah C. Mann
RQRobert A. Quaife
Robert A. Quaife
EGEdward A. Gill
Edward A. Gill
MBMichael R. Bristow
Michael R. Bristow
SARS-CoV-2 vaccine–associated myocarditis/myocardial injury should be evaluated in the contexts of COVID-19 infection, other types of viral myocarditis, and other vaccine-associated cardiac disorders. COVID-19 vaccine–associated myocardial injury can be caused by an inflammatory immune cell infiltrate, but other etiologies such as microvascular thrombosis are also possible. The clinical diagnosis is typically based on symptoms and cardiac magnetic resonance imaging. Endomyocardial biopsy is confirmatory for myocarditis, but may not show an inflammatory infiltrate because of rapid resolution or a non-inflammatory etiology. Myocarditis associated with SARS-COVID-19 vaccines occurs primarily with mRNA platform vaccines, which are also the most effective. In persons aged >16 or >12 years the myocarditis estimated crude incidences after the first 2 doses of BNT162b2 and mRNA-1273 are approximately 1.9 and 3.5 per 100 000 individuals, respectively. These rates equate to excess incidences above control populations of approximately 1.2 (BNT162b2) and 1.9 (mRNA-1273) per 100 000 persons, which are lower than the myocarditis rate for smallpox but higher than that for influenza vaccines. In the studies that have included mRNA vaccine and SARS-COVID-19 myocarditis measured by the same methodology, the incidence rate was increased by 3.5-fold over control in COVID-19 compared with 1.5-fold for BNT162b2 and 6.2-fold for mRNA-1273. However, mortality and major morbidity are less and recovery is faster with mRNA vaccine–associated myocarditis compared to COVID-19 infection. The reasons for this include vaccine-associated myocarditis having a higher incidence in young adults and adolescents, typically no involvement of other organs in vaccine-associated myocarditis, and based on comparisons to non-COVID viral myocarditis an inherently more benign clinical course.

3 December 2013 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Open access
PDF file
EREmily Sue Ruckdeschel
Emily Sue Ruckdeschel
RQRobert Quaife
Robert Quaife
LLLaurent Lewkowiez
Laurent Lewkowiez
JKJoseph Kay
Joseph Kay
WSWilliam H. Sauer
William H. Sauer
DNDuy T Nguyen
Duy T Nguyen
The purpose of this study is to review a series of patients with complex congenital heart disease in whom preprocedural imaging was used to assist placement of cardiac resynchronization therapy (CRT) leads. CRT may be beneficial in patients with a failing systemic ventricle and transposition of the great arteries (TGA). However, complex coronary venous anatomy can be challenging for placement of CRT leads. Between October 2006 and June 2012, seven patients with either dextro-TGA (d-TGA) or levo-TGA (l-TGA) underwent preprocedural imaging prior to placement of CRT leads (three, d-TGA and four, l-TGA). Three patients underwent cardiac computed tomography (CT) and four underwent coronary angiography, which included levophase imaging of the coronary sinus (CS) or direct contrast injection of the CS. Where CS anatomy was appropriate with drainage into the systemic venous circulation, a transvenous approach was planned. In all other cases, the patient was referred for surgical placement of epicardial leads. Seven patients were identified with either d-TGA or l-TGA who had undergone preprocedural imaging prior to placement of CRT leads (three, d-TGA and four, l-TGA). Three patients underwent cardiac CT and four underwent coronary angiography, which included levophase imaging of the CS or direct contrast injection of the CS. All seven patients had successful CRT lead placement guided by preprocedure imaging. Three patients required surgical placement whereas four were able to undergo transvenous placement. There were no complications. The majority of patients (four of seven) had improvement in New York Heart Association class as well as subjective improvement in exercise tolerance and energy. The majority of patients also had subjective improvement in systemic right ventricular function by echocardiogram and objective improvement in fractional area change of the right ventricle. The follow-up period ranged from 13 months to 55 months with a mean follow-up of 39 months. Placement of biventricular leads for CRT in patients with l-TGA or d-TGA is feasible. Preprocedural imaging of the CS allows for better assessment of its anatomy and helps determine procedural approach for CRT placement, thereby limiting unnecessary procedures. In the majority of patients, there was subjective improvement in functional status and right ventricular function; in addition, there was objective improvement in echocardiographic parameters of right ventricular function after CRT placement.

1 June 2013 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
TBTami J. Bang
Tami J. Bang
TSThomas Suby-Long
Thomas Suby-Long
JBJames P. Borgstede
James P. Borgstede
RQRobert Quaife
Robert Quaife
NPNancy Pritchard
Nancy Pritchard
NRNicole Restauri
Nicole Restauri

1 April 2014 in The American Journal of Cardiology
Verified
Journal Article
Closed access
TMTravis J. Moss
Travis J. Moss
MKMori J. Krantz
Mori J. Krantz
MZMatthew M. Zipse
Matthew M. Zipse
RQRobert A. Quaife
Robert A. Quaife
WSWilliam H. Sauer
William H. Sauer
JSJoseph L. Schuller
Joseph L. Schuller

1 July 2021 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
TGT. Genders
T. Genders
JRJ. Rice
J. Rice
MKM. Kriss
M. Kriss
JBJ. Burton
J. Burton
DGD. Groves
D. Groves
JMJ. Moloo
J. Moloo

13 August 2010 in Current Cardiovascular Imaging Reports
Verified
Journal Article
Closed access
PDF file
ESErnesto E. Salcedo
Ernesto E. Salcedo
JMJamaluddin Moloo
Jamaluddin Moloo
RQRobert Quaife
Robert Quaife
EWEugene Wolfel
Eugene Wolfel